| Literature DB >> 26288753 |
Dorian Pustina1, Brian Avants2, Michael Sperling3, Richard Gorniak4, Xiaosong He3, Gaelle Doucet3, Paul Barnett3, Scott Mintzer3, Ashwini Sharan5, Joseph Tracy6.
Abstract
Pre-surgical evaluation of patients with temporal lobe epilepsy (TLE) relies on information obtained from multiple neuroimaging modalities. The relationship between modalities and their combined power in predicting the seizure focus is currently unknown. We investigated asymmetries from three different modalities, PET (glucose metabolism), MRI (cortical thickness), and diffusion tensor imaging (DTI; white matter anisotropy) in 28 left and 30 right TLE patients (LTLE and RTLE). Stepwise logistic regression models were built from each modality separately and from all three combined, while bootstrapped methods and split-sample validation verified the robustness of predictions. Among all multimodal asymmetries, three PET asymmetries formed the best predictive model (100% success in full sample, >95% success in split-sample validation). The combinations of PET with other modalities did not perform better than PET alone. Probabilistic classifications were obtained for new clinical cases, which showed correct lateralization for 7/7 new TLE patients (100%) and for 4/5 operated patients with discordant or non-informative PET reports (80%). Metabolism showed closer relationship with white matter in LTLE and closer relationship with gray matter in RTLE. Our data suggest that metabolism is a powerful modality that can predict seizure laterality with high accuracy, and offers high value for automated predictive models. The side of epileptogenic focus can affect the relationship of metabolism with brain structure. The data and tools necessary to obtain classifications for new TLE patients are made publicly available.Entities:
Keywords: Asymmetry; Classification; Machine learning; Metabolism; Resection
Mesh:
Year: 2015 PMID: 26288753 PMCID: PMC4536304 DOI: 10.1016/j.nicl.2015.07.010
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Values indicate average ± standard deviation. Abbreviations: MTS = mesial temporal sclerosis, MTL = mesial temporal lobe, CPS = complex partial seizures, GTCS = generalized tonic-clonic seizures, SPS = simple partial seizures, w/2° GTCS = with secondary generalization, rare GTCS = ten or less GTCS episodes in lifetime.
| LTLE | RTLE | |
|---|---|---|
| N | 28 | 30 |
| Age | 42.4 ± 12.1 | 39.6 ± 14.9 |
| Gender F/M | 15/13 | 13/17 |
| Intracranial volume (l) | 1.39 ± 0.23 | 1.43 ± 0.25 |
| Edinburgh handedness | 84 ± 41.4 | 58 ± 65.1 |
| Full Scale IQ | 95.8 ± 14.4 | 95.1 ± 13.1 |
| Age at epilepsy onset | 22.3 ± 15.1 | 21.0 ± 12.0 |
| Duration of epilepsy (yrs) | 20.1 ± 15.3 | 18.6 ± 15.1 |
| MTS/non-MTS | 12/16 | 10/20 |
| MRI-negative | 9 (3 implanted) | 14 (4 implanted) |
| Non-MTS | 1 — L cavernous hemangioma in fusiform g. (10 mm) | 1 — enlarged R temporal horn |
| Seizure types | 12 — CPS only | 13 — CPS only |
| Medication | 6 — Carbamazepine | 3 — Carbamazepine |
Fig. 1Multimodal asymmetries of the mean (A), variance (B), kurtosis (C), and skewness (D) in LTLE (red boxes) and RTLE (green boxes). Boxplots extend between 25th and 75th percentile of the data, the central line indicates the median value. Whiskers extend to the most extreme non-outlier data point (outliers values = 1.5 × interquartile range value). The main dataset consists in data from A, the extended dataset consists in data from A–B–C–D. Asterisks mark significant group differences (Wilcoxon tests) after multiple comparison correction.
Fig. 2Bootstrapped validation of model 2 (upper panels) and model 3 (lower panels). Left panels: split-sample validation accuracy. Middle panels: split-sample posterior probability. Right panels: distribution of posterior probability from 10,000 full-sample bootstraps. Note, the posterior probability of LTLE was flipped for comparison with RTLE (i.e., 0.03 became 0.97).
The column labeled “PET prediction asymmetries” shows values used as input to the prediction, and correspond to asymmetries of PET-mesial, PET-hippo-var, and PET-entire-var, respectively. Surgeries for “New TLE” were performed during the past 12 months. Abbreviations: L = left, R = right, TL = temporal lobe, MTS = mesial temporal sclerosis, ATL = anterior temporal lobectomy, CPS = complex partial seizures, GTCS = generalized tonic-clonic seizures, SPS = simple partial seizures, w/2° GTCS = with secondary generalization, rare GTCS = ten or less GTCS episodes in lifetime.
| ID | Seizure | Ictal | MRI inspection | PET | Clinical decision | PET prediction asymmetries | Probabilistic classification | 95% CI posterior probability | Surgery + outcome |
|---|---|---|---|---|---|---|---|---|---|
| New TLE | |||||||||
| 1-LO | CPS, | L TL electrodes | L MTS | L anter. TL hypo. | LTLE | 0.01553 | LTLE | [0.027–0.339] | ATL + Class I |
| 2-FU | CPS, rareGTCS | L TL and frontal electrodes | Unremarkable | Bil. TL hypo, biased to left | LTLE | 0.04544 | LTLE | [0–0.01] | n.a. |
| 3-RA | CPS | L frontal electrodes | Unremarkable | L later. TL hypo. | LTLE | 0.00434 | LTLE | [0.04–0.36] | Implants + ATL + Class I |
| 4-NE | CPS, | L frontal electrodes | L MTS | L TL hypo. | LTLE | 0.03004 | LTLE | [0–0.05] | Laser ablation + Class I |
| 5-GM | CPS, rare GTCS | R Temporal electrodes | R MTS | R TL hypo. | RTLE | −0.05851 | RTLE | [0.99–1] | Laser ablation + Class I |
| 6-OL | SPS, | R TL electrodes | R MTS | R TL hypo. | RTLE | −0.03744 | RTLE | [0.63–0.99] | ATL + Class I |
| 7-NL | SPS, | R TL electrodes | General atrophy, larger R amygdala | Mild R mesial TL hypo. | RTLE | −0.02331 | RTLE | [0.44–0.99] | ATL + Class I |
| Ambiguous cases | |||||||||
| 1-RD | CPS, rare GTCS | L TL electrodes | Hyperintensity in R frontal, R periventricular, L caudate, and mild R hippocampal atrophy | Bilateral hypo, biased to left | LTLE | 0.00729 | LTLE | [0.075–0.389] | Implants + ATL + Class I |
| 2-VO | SPS, | L TL electrodes | L MTS | Bilateral hypo. | LTLE | 0.02933 | LTLE | [0.001–0.157] | Laser ablation + Class I |
| 3-VD | CPS | L TL electrodes | L MTS | Bilateral hypo. | LTLE | 0.04426 | LTLE | [0–0.004] | ATL + Class I |
| 4-CS | CPS, | L TL electrodes | Unremarkable | Unremarkable | LTLE | 0.02901 0.12306 0.15600 | LTLE | [0–0.01] | Implants + ATL + Class I |
| 5-LN | SPS, | L TL electrodes | Unremarkable | Unremarkable | LTLE | −0.01649 | RTLE | [0.289–0.981] | Implants + ATL + Class I |